Literature DB >> 2353114

Safe use of an intravenous power injector for CT: experience and protocol.

S G Miles1, J F Rasmussen, T Litwiller, A Osik.   

Abstract

Use of a power injector to deliver contrast material intravenously for computed tomography is a safe alternative to a bolus or drip infusion technique. The authors performed 5,280 injections at rates of 0.5-5.0 mL/sec. Six extravasations occurred, and none resulted in long-term sequelae. This complication rate is 0.1%.

Mesh:

Substances:

Year:  1990        PMID: 2353114     DOI: 10.1148/radiology.176.1.2353114

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  5 in total

1.  Frequency, outcome, and risk factors of contrast media extravasation in 142,651 intravenous contrast-enhanced CT scans.

Authors:  Eui Jin Hwang; Cheong-Il Shin; Young Hun Choi; Chang Min Park
Journal:  Eur Radiol       Date:  2018-06-06       Impact factor: 5.315

2.  Evaluation of the acute adverse reaction of contrast medium with high and moderate iodine concentration in patients undergoing computed tomography.

Authors:  Masashi Nagamoto; Tatsuya Gomi; Hitoshi Terada; Shigehiko Terada; Eiichi Kohda
Journal:  Radiat Med       Date:  2006-12-25

3.  Extravasation of radiographic contrast material and compartment syndrome in the hand: a case report.

Authors:  Tomas Belzunegui; Clint Jean Louis; Laura Torrededia; Julio Oteiza
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2011-02-04       Impact factor: 2.953

4.  Extravasation of contrast medium during CT examination: an observational case-control study.

Authors:  Zayneb Alami; Siham Nasri; Samir Ahid; Hanane Hadj Kacem
Journal:  Pan Afr Med J       Date:  2015-01-30

5.  Intravenous contrast medium extravasation: systematic review and updated ESUR Contrast Media Safety Committee Guidelines.

Authors:  Giles Roditi; Nadir Khan; Aart J van der Molen; Marie-France Bellin; Michele Bertolotto; Torkel Brismar; Jean-Michel Correas; Ilona A Dekkers; Remy W F Geenen; Gertraud Heinz-Peer; Andreas H Mahnken; Carlo C Quattrocchi; Alexander Radbruch; Peter Reimer; Laura Romanini; Fulvio Stacul; Henrik S Thomsen; Olivier Clément
Journal:  Eur Radiol       Date:  2022-02-17       Impact factor: 7.034

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.